Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 285

1.

Six months versus 12 months dual antiplatelet therapy after drug-eluting stent implantation in ST-elevation myocardial infarction (DAPT-STEMI): randomised, multicentre, non-inferiority trial.

Kedhi E, Fabris E, van der Ent M, Buszman P, von Birgelen C, Roolvink V, Zurakowski A, Schotborgh CE, Hoorntje JCA, Eek CH, Cook S, Togni M, Meuwissen M, van Royen N, van Vliet R, Wedel H, Delewi R, Zijlstra F.

BMJ. 2018 Oct 2;363:k3793. doi: 10.1136/bmj.k3793.

2.

Fracture Risk After Gastric Bypass Surgery: A Retrospective Cohort Study.

Axelsson KF, Werling M, Eliasson B, Szabo E, Näslund I, Wedel H, Lundh D, Lorentzon M.

J Bone Miner Res. 2018 Jul 16. doi: 10.1002/jbmr.3553. [Epub ahead of print]

PMID:
30011091
3.

Adiponectin, Free Fatty Acids, and Cardiovascular Outcomes in Patients With Type 2 Diabetes and Acute Coronary Syndrome.

Schrieks IC, Nozza A, Stähli BE, Buse JB, Henry RR, Malmberg K, Neal B, Nicholls SJ, Rydén L, Mellbin L, Svensson A, Wedel H, Weichert A, Lincoff AM, Tardif JC, Grobbee DE, Schwartz GG.

Diabetes Care. 2018 Aug;41(8):1792-1800. doi: 10.2337/dc18-0158. Epub 2018 Jun 14.

4.

Homeostasis Model Assessment of Insulin Resistance and Survival in Patients With Diabetes and Acute Coronary Syndrome.

Stähli BE, Nozza A, Schrieks IC, Buse JB, Malmberg K, Mellbin L, Neal B, Nicholls SJ, Rydén L, Svensson A, Wedel H, Weichert A, Lincoff AM, Grobbee DE, Tardif JC, Schwartz GG.

J Clin Endocrinol Metab. 2018 Jul 1;103(7):2522-2533. doi: 10.1210/jc.2017-02772.

PMID:
29659887
5.

A Randomized Clinical Trial of the Effect of Continuous Glucose Monitoring on Nocturnal Hypoglycemia, Daytime Hypoglycemia, Glycemic Variability, and Hypoglycemia Confidence in Persons with Type 1 Diabetes Treated with Multiple Daily Insulin Injections (GOLD-3).

Ólafsdóttir AF, Polonsky W, Bolinder J, Hirsch IB, Dahlqvist S, Wedel H, Nyström T, Wijkman M, Schwarcz E, Hellman J, Heise T, Lind M.

Diabetes Technol Ther. 2018 Apr;20(4):274-284. doi: 10.1089/dia.2017.0363. Epub 2018 Apr 2.

6.

Lung transplantation after allogeneic stem cell transplantation: a pan-European experience.

Greer M, Berastegui C, Jaksch P, Benden C, Aubert J, Roux A, Lhuillier E, Hirschi S, Reynaud-Gaubert M, Philit F, Claustre J, LePalud P, Stern M, Knoop C, Vos R, Verschuuren E, Fisher A, Riise G, Hansson L, Iversen M, Hämmäinen P, Wedel H, Smits J, Gottlieb J, Holm AM.

Eur Respir J. 2018 Feb 14;51(2). pii: 1701330. doi: 10.1183/13993003.01330-2017. Print 2018 Feb.

PMID:
29444913
7.

Impact of Thrombus Aspiration on Mortality, Stent Thrombosis, and Stroke in Patients With ST-Segment-Elevation Myocardial Infarction: A Report From the Swedish Coronary Angiography and Angioplasty Registry.

Angerås O, Haraldsson I, Redfors B, Fröbert O, Petursson P, Albertsson P, Ioanes D, Odenstedt J, Olsson H, Witt N, Rück A, Millgård J, Nilsson J, Persson J, Söderbom M, Wedel H, Erlinge D, James S, Råmunddal T, Omerovic E.

J Am Heart Assoc. 2018 Jan 9;7(1). pii: e007680. doi: 10.1161/JAHA.117.007680.

8.

Beta-blockers for heart failure with reduced, mid-range, and preserved ejection fraction: an individual patient-level analysis of double-blind randomized trials.

Cleland JGF, Bunting KV, Flather MD, Altman DG, Holmes J, Coats AJS, Manzano L, McMurray JJV, Ruschitzka F, van Veldhuisen DJ, von Lueder TG, Böhm M, Andersson B, Kjekshus J, Packer M, Rigby AS, Rosano G, Wedel H, Hjalmarson Å, Wikstrand J, Kotecha D; Beta-blockers in Heart Failure Collaborative Group.

Eur Heart J. 2018 Jan 1;39(1):26-35. doi: 10.1093/eurheartj/ehx564.

9.

Risk of atrial fibrillation in people with type 1 diabetes compared with matched controls from the general population: a prospective case-control study.

Dahlqvist S, Rosengren A, Gudbjörnsdottir S, Pivodic A, Wedel H, Kosiborod M, Svensson AM, Lind M.

Lancet Diabetes Endocrinol. 2017 Oct;5(10):799-807. doi: 10.1016/S2213-8587(17)30262-0. Epub 2017 Aug 30.

PMID:
28838683
10.

Glycaemic control and excess risk of major coronary events in persons with type 1 diabetes.

Matuleviciene-Anängen V, Rosengren A, Svensson AM, Pivodic A, Gudbjörnsdottir S, Wedel H, Kosiborod M, Haraldsson B, Lind M.

Heart. 2017 Nov;103(21):1687-1695. doi: 10.1136/heartjnl-2016-311050. Epub 2017 Jul 14.

PMID:
28710186
11.

Association Between Alendronate Use and Hip Fracture Risk in Older Patients Using Oral Prednisolone.

Axelsson KF, Nilsson AG, Wedel H, Lundh D, Lorentzon M.

JAMA. 2017 Jul 11;318(2):146-155. doi: 10.1001/jama.2017.8040.

12.

A prospective, randomized, open-label trial of 6-month versus 12-month dual antiplatelet therapy after drug-eluting stent implantation in ST-elevation myocardial infarction: Rationale and design of the "DAPT-STEMI trial".

Kedhi E, Fabris E, van der Ent M, Kennedy MW, Buszman P, von Birgelen C, Cook S, Wedel H, Zijlstra F.

Am Heart J. 2017 Jun;188:11-17. doi: 10.1016/j.ahj.2017.02.018. Epub 2017 Feb 20.

PMID:
28577666
13.

Heart Rate and Rhythm and the Benefit of Beta-Blockers in Patients With Heart Failure.

Kotecha D, Flather MD, Altman DG, Holmes J, Rosano G, Wikstrand J, Packer M, Coats AJS, Manzano L, Böhm M, van Veldhuisen DJ, Andersson B, Wedel H, von Lueder TG, Rigby AS, Hjalmarson Å, Kjekshus J, Cleland JGF; Beta-Blockers in Heart Failure Collaborative Group.

J Am Coll Cardiol. 2017 Jun 20;69(24):2885-2896. doi: 10.1016/j.jacc.2017.04.001. Epub 2017 Apr 30. Review.

14.

Continuous Glucose Monitoring vs Conventional Therapy for Glycemic Control in Adults With Type 1 Diabetes Treated With Multiple Daily Insulin Injections: The GOLD Randomized Clinical Trial.

Lind M, Polonsky W, Hirsch IB, Heise T, Bolinder J, Dahlqvist S, Schwarz E, Ólafsdóttir AF, Frid A, Wedel H, Ahlén E, Nyström T, Hellman J.

JAMA. 2017 Jan 24;317(4):379-387. doi: 10.1001/jama.2016.19976. Erratum in: JAMA. 2017 May 9;317(18):1912.

PMID:
28118454
15.

A lifestyle intervention in primary care prevents deterioration of insulin resistance in patients with impaired glucose tolerance: A randomised controlled trial.

Hellgren MI, Jansson PA, Wedel H, Lindblad U.

Scand J Public Health. 2016 Nov;44(7):718-725. doi: 10.1177/1403494816663539. Epub 2016 Aug 22.

PMID:
27550085
16.

Prognostic Impact of Chronic Total Occlusions: A Report From SCAAR (Swedish Coronary Angiography and Angioplasty Registry).

Råmunddal T, Hoebers LP, Henriques JP, Dworeck C, Angerås O, Odenstedt J, Ioanes D, Olivecrona G, Harnek J, Jensen U, Aasa M, Albertsson P, Wedel H, Omerovic E.

JACC Cardiovasc Interv. 2016 Aug 8;9(15):1535-44. doi: 10.1016/j.jcin.2016.04.031.

17.

Glycemic Control, Renal Complications, and Current Smoking in Relation to Excess Risk of Mortality in Persons With Type 1 Diabetes.

Ahlén E, Pivodic A, Wedel H, Dahlqvist S, Kosiborod M, Lind M.

J Diabetes Sci Technol. 2016 Aug 22;10(5):1006-14. doi: 10.1177/1932296816652901. Print 2016 Sep.

18.

Effect of age and sex on efficacy and tolerability of β blockers in patients with heart failure with reduced ejection fraction: individual patient data meta-analysis.

Kotecha D, Manzano L, Krum H, Rosano G, Holmes J, Altman DG, Collins PD, Packer M, Wikstrand J, Coats AJ, Cleland JG, Kirchhof P, von Lueder TG, Rigby AS, Andersson B, Lip GY, van Veldhuisen DJ, Shibata MC, Wedel H, Böhm M, Flather MD; Beta-Blockers in Heart Failure Collaborative Group.

BMJ. 2016 Apr 20;353:i1855. doi: 10.1136/bmj.i1855. Review.

19.

Excess Mortality among Persons with Type 2 Diabetes.

Lind M, Wedel H, Rosengren A.

N Engl J Med. 2016 Feb 25;374(8):788-9. doi: 10.1056/NEJMc1515130. No abstract available.

20.

Loop diuretics, renal function and clinical outcome in patients with heart failure and reduced ejection fraction.

Damman K, Kjekshus J, Wikstrand J, Cleland JG, Komajda M, Wedel H, Waagstein F, McMurray JJ.

Eur J Heart Fail. 2016 Mar;18(3):328-36. doi: 10.1002/ejhf.462. Epub 2015 Dec 23.

Supplemental Content

Loading ...
Support Center